Spinal Muscular Atrophy (SMA) Clinical Trials

Find Spinal Muscular Atrophy (SMA) Clinical Trials Near You

Observational Study for the Identification of Fatigue and Gait Biomarkers in Populations With Neuromuscular Pathologies in the Clinical Context and Daily Life

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Other
Study Type: Observational
SUMMARY

This study has the general objective of observing walking parameters during a clinical test to objectively estimate fatigue in patients with neuromuscular diseases. Furthermore, the investigators want to evaluate the feasibility of collecting physical activity in daily life conditions during a one-week monitoring period using a wearable sensor.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 75
Healthy Volunteers: t
View:

• Ambulant adult patients with genetic diagnosis of muscular dystrophy/myopathy (dystrophinopathies, muscular dystrophies and congenital and non-congenital myopathies), of spinal muscular atrophy (SMA) and with molecular diagnosis of Charcot-Marie Tooth 1 or 2.

• independent walking, even with assistance;

Locations
Other Locations
Italy
Scientific Institute IRCCS E. Medea - Sede di Bosisio Parini
RECRUITING
Bosisio Parini
Scientific Institute IRCCS E. Medea - Polo di Conegliano
NOT_YET_RECRUITING
Conegliano
Contact Information
Primary
Fabio A Storm, PhD
fabio.storm@lanostrafamiglia.it
+39031877111
Backup
Emilia Biffi, PhD
emilia.biffi@lanostrafamiglia.it
+39031877111
Time Frame
Start Date: 2017-10-27
Estimated Completion Date: 2026-12
Participants
Target number of participants: 120
Treatments
Group with neuromuscular disease
Control Group
Sponsors
Leads: IRCCS Eugenio Medea

This content was sourced from clinicaltrials.gov